Petersen T - Search Results

1

Functioning and interpersonal relationships as predictors of response in treatment-resistant depression.

Papakostas GI, Petersen T, Mischoulon D, Hughes ME, Spector AR, Alpert JE, Fava M, Nierenberg AA. Papakostas GI, et al. Among authors: petersen t. Compr Psychiatry. 2003 Jan-Feb;44(1):44-50. doi: 10.1053/comp.2003.50012. Compr Psychiatry. 2003. PMID: 12524635

2

Treatment resistant depression and axis I co-morbidity.

Petersen T, Gordon JA, Kant A, Fava M, Rosenbaum JF, Nierenberg AA. Petersen T, et al. Psychol Med. 2001 Oct;31(7):1223-9. doi: 10.1017/s0033291701004305. Psychol Med. 2001. PMID: 11681548

3

Use of the five-factory inventory in characterizing patients with major depressive disorder.

Petersen T, Bottonari K, Alpert JE, Fava M, Nierenberg AA. Petersen T, et al. Compr Psychiatry. 2001 Nov-Dec;42(6):488-93. doi: 10.1053/comp.2001.27897. Compr Psychiatry. 2001. PMID: 11704941 Clinical Trial.

4

NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients.

Petersen T, Papakostas GI, Bottonari K, Iacoviello B, Alpert JE, Fava M, Nierenberg AA. Petersen T, et al. Psychiatry Res. 2002 Jan 31;109(1):9-16. doi: 10.1016/s0165-1781(01)00359-6. Psychiatry Res. 2002. PMID: 11850046 Clinical Trial.

5

A survey of prescribing practices in the treatment of depression.

Petersen T, Dording C, Neault NB, Kornbluh R, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M. Petersen T, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jan;26(1):177-87. doi: 10.1016/s0278-5846(01)00250-0. Prog Neuropsychopharmacol Biol Psychiatry. 2002. PMID: 11853110

6

Body dysmorphic disorder in outpatients with major depression.

Nierenberg AA, Phillips KA, Petersen TJ, Kelly KE, Alpert JE, Worthington JJ, Tedlow JR, Rosenbaum JF, Fava M. Nierenberg AA, et al. J Affect Disord. 2002 May;69(1-3):141-8. doi: 10.1016/s0165-0327(01)00304-4. J Affect Disord. 2002. PMID: 12103460

7

Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder.

Sonawalla SB, Papakostas GI, Petersen TJ, Yeung AS, Smith MM, Sickinger AH, Gordon J, Israel JA, Tedlow JR, Lamon-Fava S, Fava M. Sonawalla SB, et al. Psychosomatics. 2002 Jul-Aug;43(4):310-6. doi: 10.1176/appi.psy.43.4.310. Psychosomatics. 2002. PMID: 12189257

8

Treatment-resistant depression and Axis II comorbidity.

Petersen T, Hughes M, Papakostas GI, Kant A, Fava M, Rosenbaum JF, Nierenberg AA. Petersen T, et al. Psychother Psychosom. 2002 Sep-Oct;71(5):269-74. doi: 10.1159/000064808. Psychother Psychosom. 2002. PMID: 12207107 Clinical Trial.

9

A survey of prescribing preferences in the treatment of refractory depression: recent trends.

Kornbluh R, Papakostas GI, Petersen T, Neault NB, Nierenberg AA, Rosenbaum JF, Fava M. Kornbluh R, et al. Among authors: petersen t. Psychopharmacol Bull. 2001 Summer;35(3):150-6. Psychopharmacol Bull. 2001. PMID: 12397884

10

Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants.

Nierenberg AA, Papakostas GI, Petersen T, Montoya HD, Worthington JJ, Tedlow J, Alpert JE, Fava M. Nierenberg AA, et al. Among authors: petersen t. J Clin Psychopharmacol. 2003 Feb;23(1):92-5. doi: 10.1097/00004714-200302000-00013. J Clin Psychopharmacol. 2003. PMID: 12544380 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,403 results

Search Page

Filters